🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

182 results for “Ars” Clear

  1. Prednisolone 5mg Soluble Tablets, Certican 0,75 mg tablety, Mycofenolaat mofetil Sandoz 250 mg, capsules, hard, Envarsus 0.75 mg prolonged-release tablets, Simulect 20 mg powder and solvent for solution for injection or infusion, Ciclosporine Teva 25 mg, zachte capsules

    Disc Medicine

    kidney transplant

    approved small molecule active

    1 trial

  2. SARS-CoV-2 Inactivated Vaccine

    Sinovac Research and Development Co.,

    COVID-19

    approved mab active

    2 trials

  3. Sparsentan

    Travere Therapeutics

    Proteinuria

    approved small molecule active

    1 trial

  4. Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine

    Moderna Biotech Spain

    SARS-CoV-2 infection

    approved small molecule active

    1 trial

  5. Two doses of inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 and one dose Quadrivalent Influenza Vaccine on day 0 or day 28.

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    1 trial

  6. Azvudine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    SARS-CoV-2 Infection

    small molecule active

    1 trial

  7. ClearSight HPI Monitoring system

    Grace Therapeutics

    Anesthesia, Epidural

    other completed

    1 trial

  8. Probiotics daily

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    SARS-CoV-2

    other completed

    1 trial

  9. SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine

    The First People's Hospital of Lianyungang

    SARS-CoV-2

    mab active

    1 trial

  10. SARS-CoV-2 mRNA Vaccine, Bivalent Low dose

    The First People's Hospital of Lianyungang

    SARS-CoV-2

    mab active

    1 trial

  11. Sniffing emotional tears

    Hospital Authority, Hong Kong

    Obesity

    mab completed

    1 trial

  12. Standart medical treatment

    Tarsus Pharmaceuticals

    High Intensity Interval Training

    small molecule active

    1 trial

  13. Tranexamic Acid 100Mg/Ml Inj Vil 10Ml

    Hospital Authority, Hong Kong

    Rotator Cuff Tears

    small molecule completed

    1 trial

  14. Uteratonic administration

    Tarsus Pharmaceuticals

    Placenta Abruptio

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources